GlassScriptPhysician profile
Barbara Ann Misiano
NPI 1376999011
$1,451.69
in general payments reported to CMS, 2019-2025
10 companies · $624 in 2025
The $624 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $234 · 2024: $593 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $353.10 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $215.86 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $176.38 | 2025 | Camzyos |
| Abbott Laboratories | $150.00 | 2024 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $128.21 | 2023-2025 | |
| Scpharmaceuticals INC. | $124.98 | 2025 | |
| Alnylam Pharmaceuticals INC. | $108.25 | 2025 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $105.43 | 2023 | |
| Novo Nordisk INC | $60.67 | 2024 | |
| Neurocrine Biosciences, INC. | $28.81 | 2023 | Ingrezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Misiano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.